Vaccinated animals receiving lymphatic combinational treatment exhibited significantly reduced tumor sizes, improved survival, greater Melan-A functionality of CD8+ and CD4+ PBMCs, and, in an orthotopic model, decreased the metastatic burden as indicated by blood Pmel17 RNA expression, than when dosed systemically. The gene discussed is CD8A; the disease is neoplasm.